Ken Griffin Neuro Sense Therapeutics Ltd. Transaction History
Citadel Advisors LLC
- $505 Billion
- Q3 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Neuro Sense Therapeutics Ltd. stock. As of the latest transaction made, Citadel Advisors LLC holds 34,280 shares of NRSN stock, worth $43,878. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,280Holding current value
$43,878% of portfolio
0.0%Shares
2 transactions
Others Institutions Holding NRSN
# of Institutions
8Shares Held
225KCall Options Held
0Put Options Held
0-
Cantor Fitzgerald, L. P. New York, NY79.5KShares$101,7490.01% of portfolio
-
Xtx Topco LTD London, X046KShares$58,8740.0% of portfolio
-
Meitav Dash Investments LTD40KShares$51,2000.0% of portfolio
-
Commonwealth Equity Services, LLC12.6KShares$16,1600.0% of portfolio
-
Geode Capital Management, LLC Boston, MA12KShares$15,3120.0% of portfolio
About NeuroSense Therapeutics Ltd.
- Ticker NRSN
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 11,674,000
- Market Cap $14.9M